TERN (TERN) - Stock Analysis
Last updated: Mar 25, 2026
Closed
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Merger-arbitrage hot trade: Merck's agreed acquisition of Terns at $53/share has driven a ~28% 21-day rally to ~$52.8, leaving a small spread to the deal price. Strong momentum, clear upside anchored by the cash offer, and active option/institutional interest make TERN an event-driven "hot idea" for traders targeting completion of the transaction, subject to legal/closure risks.
Loading chart data...
Idea window: 3/25/2026 – 4/1/2026Sector:
AI Analyst Overview
Loading AI Analyst data...
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Mar 25 | Apr 1 | TERN | TERN | Merger-arbitrage hot trade: Merck's agreed acquisition of Terns at $53/share has driven a ~28% 21-day rally to ~$52.8, leaving a small spread to the deal price. Strong momentum, clear upside anchored by the cash offer, and active option/institutional interest make TERN an event-driven "hot idea" for traders targeting completion of the transaction, subject to legal/closure risks. | Closed | -0.1% |
| Dec 11 | Dec 18 | TERN | TERN | Exceptional short-term momentum following highly positive Phase 1/2 CARDINAL trial data in refractory CML and a $650 million equity raise; 116% price gain over past month and strong institutional demand; significant dilution and technical overextension increase volatility risk; positioned as a speculative hot idea tethered to ongoing clinical developments and regulatory milestones. | Closed | -15.5% |